[go: up one dir, main page]

DE60029946D1 - Arzneimittel gegen glomerulosclerose - Google Patents

Arzneimittel gegen glomerulosclerose

Info

Publication number
DE60029946D1
DE60029946D1 DE60029946T DE60029946T DE60029946D1 DE 60029946 D1 DE60029946 D1 DE 60029946D1 DE 60029946 T DE60029946 T DE 60029946T DE 60029946 T DE60029946 T DE 60029946T DE 60029946 D1 DE60029946 D1 DE 60029946D1
Authority
DE
Germany
Prior art keywords
glomerulosclerosis
drug against
present
pregnatriene
methylbutyloxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60029946T
Other languages
English (en)
Other versions
DE60029946T2 (de
Inventor
Toshio Doi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE60029946D1 publication Critical patent/DE60029946D1/de
Application granted granted Critical
Publication of DE60029946T2 publication Critical patent/DE60029946T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60029946T 1999-05-10 2000-05-09 Arzneimittel gegen glomerulosklerose Expired - Fee Related DE60029946T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP12856699 1999-05-10
JP12856699 1999-05-10
PCT/JP2000/002958 WO2000067758A1 (en) 1999-05-10 2000-05-09 Remedies for glomerulosclerosis

Publications (2)

Publication Number Publication Date
DE60029946D1 true DE60029946D1 (de) 2006-09-21
DE60029946T2 DE60029946T2 (de) 2007-03-15

Family

ID=14987936

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60029946T Expired - Fee Related DE60029946T2 (de) 1999-05-10 2000-05-09 Arzneimittel gegen glomerulosklerose

Country Status (7)

Country Link
US (2) US6506741B1 (de)
EP (1) EP1179346B1 (de)
AT (1) ATE335491T1 (de)
AU (1) AU4146000A (de)
DE (1) DE60029946T2 (de)
TW (1) TWI226241B (de)
WO (1) WO2000067758A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1179346B1 (de) * 1999-05-10 2006-08-09 Toshio Doi Arzneimittel gegen glomerulosclerose
US20050148557A1 (en) * 2003-07-29 2005-07-07 Jin Tian Use of Vitamin Ds to treat kidney disease
WO2014152929A1 (en) 2013-03-14 2014-09-25 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona For And On Behalf Of Arizona State University Measuring glomerular number from kidney mri images

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2854600B2 (ja) * 1988-04-21 1999-02-03 中外製薬株式会社 腎炎治療薬
JPH09110717A (ja) * 1995-10-21 1997-04-28 Samu Kenkyusho:Kk ループス腎炎治療剤
GB2308282B (en) * 1995-12-15 2000-04-12 Lotus Dev Corp Differential work factor cryptography method and system
JPH09169648A (ja) * 1995-12-22 1997-06-30 Nippon Shinyaku Co Ltd 医薬組成物
JPH10306024A (ja) * 1997-03-07 1998-11-17 Kissei Pharmaceut Co Ltd 糸球体疾患の予防および治療剤
EP1179346B1 (de) * 1999-05-10 2006-08-09 Toshio Doi Arzneimittel gegen glomerulosclerose

Also Published As

Publication number Publication date
WO2000067758A1 (en) 2000-11-16
EP1179346A1 (de) 2002-02-13
EP1179346B1 (de) 2006-08-09
EP1179346A4 (de) 2003-11-12
TWI226241B (en) 2005-01-11
US20030083320A1 (en) 2003-05-01
US6506741B1 (en) 2003-01-14
DE60029946T2 (de) 2007-03-15
ATE335491T1 (de) 2006-09-15
AU4146000A (en) 2000-11-21
US6864247B2 (en) 2005-03-08

Similar Documents

Publication Publication Date Title
DE69529670D1 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
BR0015605A (pt) Composição e uso
SE8300736D0 (sv) Novel pharmacologically active compounds
ATE293995T1 (de) Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten
NO20011721D0 (no) N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor
PT97689A (pt) Processo para a preparacao de composicoes farmaceuticas incorporando como ingrediente activo isoxazol-4-carboxilamida e hidroxialquilideno-cianoacetamida
ES2081187T3 (es) Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
SE9902987D0 (sv) Novel compounds
SE9904505D0 (sv) Novel compounds
NZ516347A (en) Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them
PT1263730E (pt) Derivados amina para o tratamento de apoptose
SE9904508D0 (sv) New compounds
PA8495101A1 (es) Derivados de 13-metileritromicina
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
SE0100569D0 (sv) New compounds
NO20020282L (no) Nytt difenyl-piperidinderivat
BR0111678A (pt) Composições medicinais contendo derivados de propenona
DE60301339D1 (de) Pyrazolopyrimidin- und pyrazolotriazinderivate und diese enthaltende pharmazeutische zubereitungen
NO304113B1 (no) Krystallinsk tiagabinhydrokloridmonohydrat, farmas°ytisk preparat som omfatter det, og anvendelse derav for fremstilling av et medikament
SE0102440D0 (sv) New compound
GR3019274T3 (en) Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use
ES2116612T3 (es) Nuevas bis-naftalimidas para el tratamiento del cancer.
AR005102A1 (es) Compuestos derivados de octahidro-pirrolo [1,2-a]-pirazina 2,7-sustituidos, composiciones farmaceuticas y uso de dichos compuestos para la fabricacion deun medicamento.
DE60029946D1 (de) Arzneimittel gegen glomerulosclerose
TR200200683T2 (tr) Oral kontrollü salıverme formülasyonları.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee